SCHEMBL2352963

SCHEMBL2352963

Nc1ccc(C(=O)Oc2ccccc2C(=O)O)c(O)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.69
ALDH1A1 P00352 7/20 0.69
HSD17B10 Q99714 7/20 0.69
HPGD P15428 6/20 0.69
MAPT P10636 5/20 0.68
CYP3A4 P08684 3/20 0.68
LMNA P02545 2/20 0.68
KDR P35968 2/20 0.68
TP53 P04637 1/20 0.68
ADORA3 P0DMS8 1/20 0.68
CHRM1 P11229 1/20 0.68
TBXA2R P21731 1/20 0.68
SLC6A2 P23975 1/20 0.68
PDE4A P27815 1/20 0.68
ADRA1A P35348 1/20 0.68
SLC6A3 Q01959 1/20 0.68
SMN1; SMN2 Q16637 1/20 0.68
HDAC6 Q9UBN7 1/20 0.68
GAA P10253 3/20 0.60
ESR2 Q92731 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3628199 0.89 ALDH1A1 (0.66) KDM4EALDH1A1HSD17B10HPGDMAPT
SCHEMBL28188089 0.88 ALDH1A1 (0.64) KDM4EALDH1A1HSD17B10HPGDMAPT
Aspirin SCHEMBL27414704 0.86 KDM4E (0.67) KDM4EALDH1A1HSD17B10HPGDMAPT
SCHEMBL3278617 0.85 HSD17B10 (0.73) KDM4EALDH1A1HSD17B10HPGDMAPT
Aspirin SCHEMBL11799149 0.85 KDM4E (0.65) KDM4EALDH1A1HSD17B10HPGDMAPT
Salsalate SCHEMBL15562 0.82 HSD17B10 (1.00) KDM4EALDH1A1HSD17B10HPGDMAPT
Salsalate SCHEMBL29362887 0.82 HSD17B10 (1.00) KDM4EALDH1A1HSD17B10HPGDMAPT
Salsalate SCHEMBL2025628 0.82 HSD17B10 (1.00) KDM4EALDH1A1HSD17B10HPGDMAPT
SCHEMBL3773764 0.82 HSD17B10 (0.69) KDM4EALDH1A1HSD17B10HPGDMAPT
SCHEMBL14577689 0.82 MAPT (0.64) KDM4EALDH1A1HSD17B10HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2361620-A1 Use of aminosalicylates in diarrhoea-predominant irritable bowel syndrome PHARMATEL (R&D) PTY LIMITED as Trustee for the PHARMATEL (R & D) TRUST (AU) 2011-08-31 EP disclosed